| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Melamed Leo is a Director at CME. Recent filings cover 0 purchases and 1 sale. Those positions are worth an estimated $2.8M at current prices.
Melamed Leo's largest disclosed position is in CME as Director, worth about $2.8M. The recent filings there lean toward selling, a net 7,300 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2018 | CME Cme Group Inc. | Director | Sell | 7,300 | $155.78 | $1,137,194.00 | -40.9% |